Physician
Payne and Holloway
Payne and Holloway was paid $2.57M by Medicaid between Jan 2018 and Dec 2024, across 59 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 65% of everything it billed.
33Billing provider infoPAYNE AND HOLLOWAY
MONTGOMERY, AL 36117
MONTGOMERY, AL 36117
33aNPI1770026619assigned 11/26/2016
33bProvider typePediatrics Physician
28Total paid$2.57M
24GClaims62,820
24DCodes billed59
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Alabama
Rank by total paid#62 of 199
Median peer was paid$702K
This provider vs. median3.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,681 | $354K | |
| 2019 | 9,609 | $372K | |
| 2020 | 7,301 | $307K | |
| 2021 | 9,093 | $379K | |
| 2022 | 10,348 | $413K | |
| 2023 | 9,832 | $385K | |
| 2024incomplete | 7,956 | $359K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 65% | 20,695 | 18,339 | $1.67M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.0% | 1,946 | 1,861 | $103K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.3% | 1,558 | 1,451 | $86K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.3% | 1,618 | 1,545 | $85K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.1% | 1,432 | 1,247 | $80K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.4% | 1,187 | 1,110 | $61K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.1% | 459 | 420 | $55K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.5% | 1,557 | 1,511 | $40K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 2,772 | 2,655 | $37K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.1% | 513 | 489 | $28K |
| 83655 | 1.1% | 1,936 | 1,849 | $27K | |
| 80061 | Lipid panel | 1.0% | 2,076 | 1,957 | $26K |
47 more codes
| 90670 | <1% | 1,348 | $24K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,353 | $24K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 749 | $22K |
| 99173 | <1% | 5,022 | $18K | |
| 90686 | <1% | 900 | $16K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 140 | $15K |
| 90723 | <1% | 847 | $15K | |
| 90647 | <1% | 825 | $15K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 85 | $13K |
| 92551 | <1% | 3,842 | $13K | |
| 96127 | <1% | 2,902 | $11K | |
| 90649 | <1% | 537 | $10K | |
| 90633 | <1% | 485 | $8K | |
| 99223 | Prolong inpt eval add15 m | <1% | 53 | $8K |
| 90716 | <1% | 420 | $7K | |
| 90680 | <1% | 360 | $7K | |
| 92558 | <1% | 910 | $6K | |
| 90707 | <1% | 392 | $6K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 67 | $5K |
| 81002 | <1% | 1,491 | $4K | |
| 90734 | <1% | 189 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 36 | $3K |
| 99460 | <1% | 30 | $2K | |
| 90677 | <1% | 103 | $2K | |
| 99462 | <1% | 60 | $2K | |
| 0071A | <1% | 61 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 13 | $2K |
| 90656 | <1% | 84 | $2K | |
| 94010 | <1% | 75 | $1K | |
| 0072A | <1% | 29 | $928.00 | |
| 90715 | <1% | 39 | $732.23 | |
| 90620 | <1% | 42 | $732.23 | |
| 90696 | <1% | 61 | $725.91 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 14 | $566.93 |
| 90685 | <1% | 20 | $395.80 | |
| 81025 | <1% | 138 | $386.20 | |
| 86580 | <1% | 60 | $342.77 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 32 | $306.74 |
| 90672 | <1% | 15 | $296.85 | |
| 90700 | <1% | 15 | $296.85 | |
| 90671 | <1% | 14 | $277.06 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 16 | $276.90 |
| 85018 | <1% | 116 | $263.78 | |
| 86308 | <1% | 42 | $228.00 | |
| D1206 | Topical application of fluoride varnish | <1% | 13 | $198.00 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 13 | $130.00 |
| 99177 | <1% | 13 | $115.56 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOLLOWAY, ALBERT (OWNER)